Select Biotechnolgy PortFBIOX
13F holders, Q1 2025 (March 31)3holders +1
1new positions
0sold out
$17.85avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Select Biotechnolgy Port (FBIOX) in their 13F filings, up 1 from Q4 2024. 1 opened new positions and 0 sold out. The largest holders were Ascentis Wealth Management, LLC ($41K), Financial Gravity Asset Management, Inc. ($9K) and Coston, McIsaac & Partners ($1K).
- Company
- Select Biotechnolgy Port
- Filed as
- FIDELITY SELECT BIOTECHNOLOGY (Q1 2025)
- CUSIP
- 316390772
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $41K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 2,274 shares bought, net +2,274 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Ascentis Wealth Management, LLC | 0.01% | New | 2,274 | $41K |
| Financial Gravity Asset Management, Inc. | 0.00% | — | 475 | $9K |
| Coston, McIsaac & Partners | 0.00% | No change | 94 | $1K |
"% of holder's portfolio" is FBIOX's weight in each manager's 13F, not the share of Select Biotechnolgy Port the manager owns.